Irinotecan

Records for this ingredient, by country (identity only).

ATC L01CE02 · 12 markets · 189 records

Irinotecan 12 markets · 189 records Forms
Filters
Kind

GB 53 records · 12 shown of 17 Source NHSBSA dm+d · Data as of 2026-10-19

Only this ingredient

Other strengths: 5 · 1 dosage forms Otras concentraciones: 5 · 1 formas farmacéuticas 其余规格 5 个 · 涉及 1 种剂型 其餘規格 5 個 · 涉及 1 種劑型 · 270 mg/180 mL、260 mg/250 mL、240 mg/250 mL、220 mg/250 mL、200 mg/250 mL
injection · 5270 mg/180 mL260 mg/250 mL240 mg/250 mL220 mg/250 mL200 mg/250 mL

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

US 27 records · 2 shown of 2 Source openFDA NDC Directory · Data as of 2026-10-23

Only this ingredient

  • 20 mg per mL / per unit basis not statedinjectionCamptosarManufacturer: Actavis Pharma, Inc.、Manufacturer: Apotex Corp.、Manufacturer: BluePoint Laboratories、Manufacturer: Eugia US LLC、Manufacturer: Fresenius Kabi USA, LLC、Manufacturer: Gland Pharma Limited、Manufacturer: Hikma Pharmaceuticals USA I…、Manufacturer: Hospira, Inc. +4
  • 4.3 mg per mL / per unit basis not statedinjectionOnivyde

CN 20 records · 4 shown of 4 Source 国家医保局 医保药品分类与代码数据库 · Data as of 2025-04-04

Only this ingredient

  • 100 mg/5 mLinjectionManufacturer: 上海创诺制药有限公司 ×2Manufacturer: 仁合熙德隆药业有限公司、Manufacturer: 四川汇宇制药股份有限公司、Manufacturer: 江苏恒瑞医药股份有限公司、Manufacturer: 海南锦瑞制药有限公司、Manufacturer: 齐鲁制药(海南)有限公司 also in GB·JP·AU
  • 40 mg/2 mLinjectionManufacturer: 上海创诺制药有限公司 ×2Manufacturer: 仁合熙德隆药业有限公司、Manufacturer: 哈药集团生物工程有限公司、Manufacturer: 四川汇宇制药股份有限公司、Manufacturer: 江苏恒瑞医药股份有限公司、Manufacturer: 海南锦瑞制药有限公司、Manufacturer: 齐鲁制药(海南)有限公司 also in GB·JP
  • 100 mg per mL / per unit basis not statedinjection艾力伊立替康
  • 40 mg per mL / per unit basis not statedinjection艾力伊立替康

CA 12 records · 2 shown of 2 Source Health Canada Drug Product Databas · Data as of 2026-10-23

Only this ingredient

JP 11 records · 3 shown of 3 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

Only this ingredient

  • 100 mg/5 mLinjectionイリノテカン塩酸塩100mg5mLイリノテカン塩酸塩点滴静注液100mg「NK」、イリノテカン塩酸塩点滴静注液100mg「NP」、イリノテカン塩酸塩点滴静注液100mg「トーワ」、トポテシン点滴静注100mg also in GB·CN·AU
  • 40 mg/2 mLinjectionイリノテカン塩酸塩点滴静注液100mg「NK」イリノテカン塩酸塩点滴静注液100mg「NP」、イリノテカン塩酸塩点滴静注液100mg「トーワ」、イリノテカン塩酸塩点滴静注液40mg「SUN」、トポテシン点滴静注100mg also in GB·CN
  • 43 mg/10 mLinjectionオニバイド点滴静注43mg

ES 10 records · 3 shown of 3 Source CIMA (AEMPS) · Data as of live

Only this ingredient

AU 7 records · 2 shown of 2 Source PBS Schedule API v3 (Department of、TGA CMI repository (consumer medic · Data as of 2026-10-01、live · some records have no stated strength · includes records with unknown status (not proof of sale)

Only this ingredient

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Meditab Irinotecan ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

SG 7 records · 4 shown of 4 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

Only this ingredient

  • 100 mg/vial per mL / per unit basis not statedinjectionIRINOCAN 100 CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/ 5 MLIRINOX 100 IRINOTECAN HYDROCHLORIDE CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/ 5 ML
  • 40 mg/vial per mL / per unit basis not statedinjectionIRINOCAN 40 CONCENTRATE FOR SOLUTION FOR INFUSION 40 MG/ 2 MLIRINOX 40 IRINOTECAN HYDROCHLORIDE CONCENTRATE FOR SOLUTION FOR INFUSION 40 MG/ 2 ML
  • 20 mg/mL per mL / per unit basis not statedinjectionCAMPTO FOR INFUSION 20 mg/mlIRINOTECAN HYDROCHLORIDE ADVAGEN CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/ML
  • 4.33 mg/mL per mL / per unit basis not statedinjectionONIVYDE PEGYLATED LIPOSOMAL (IRINOTECAN) CONCENTRATE FOR DISPERSION FOR INFUSION 4.3 mg/mL

FR 6 records · 2 shown of 2 Source Base de données publique des médic · Data as of 2026-11-03

Only this ingredient

  • 20 mg/1 mLinjectionIRINOTECAN ACCORD 20 mg/mL, solution à diluer pour perfusionIRINOTECAN HIKMA 20 mg/mL, solution à diluer pour perfusion、IRINOTECAN KABI 20 mg/ml, solution à diluer pour perfusion、IRINOTECAN MEDAC 20 mg/mL, solution à diluer pour perfusion、IRINOTECAN VIATRIS 20 mg/ml, solution à diluer pour perfusion also in ES
  • 1.5 mg/1 mLinjectionIRINOTECAN SUN 1,5 mg/ml, solution pour perfusion also in ES

MX 3 records · 0 shown of 0 Source COFEPRIS · Data as of annual · some records have no stated strength

3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名ANTIRIM ×1CETABINDO ×1IRIASPE ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

HK 1 records · 0 shown of 0 Source 衞生署藥物辦公室(香港)註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名ONIVYDE PEGYLATED LIPOSOMAL CONCENTRATE FOR DISPERSION FOR INFUSION 43MG/10ML ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名ONIVYDE PEGYLATED LIPOSOMAL ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

Also called: 盐酸伊立替康 nickname

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.